Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN28271641
ISRCTN28271641
Completed
Not Applicable

Indications for and consequences of antiepileptic drug withdrawal

Akershus University Hospital (Norway)0 sites160 target enrollmentAugust 17, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEpilepsyNervous System Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Akershus University Hospital (Norway)
Enrollment
160
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 17, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Akershus University Hospital (Norway)

Eligibility Criteria

Inclusion Criteria

  • •1\. Epilepsy (minimum of two unprovoked epileptic fits)
  • •2\. Two year seizure freedom
  • •3\. Only one antiepileptic drug in use
  • •4\. Aged 18 to 67 years

Exclusion Criteria

  • •1\. Juvenile myoclonus epilepsy
  • •2\. Paroxysmal EEG activity before termination of treatment, in patients with primary generalized epilepsy
  • •3\. Using several AEDs
  • •4\. Pregnancy
  • •5\. Mental retardation
  • •6\. Progressive neurological disease
  • •7\. Other known condition, which may affect patient's condition during follow\-up
  • •8\. Other permanent medication (except in the case of contraceptive pills and hormonal treatment for menopausal conditions)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pharmacokinetic interactions between antiepileptic drugs (AED) and direct oral anticoagulants (DOAC).G40.9I48.9Epilepsy, unspecifiedAtrial fibrillation and atrial flutter, unspecified
DRKS00029398Charité – Universitätsmedizin Berlin, Klinik für Neurologie, Klinische und Experimentelle Epileptologie50
Recruiting
Not Applicable
Comparison of antiepileptic drugs in terms of their effect on quality of life and cost of treatment in person with epilepsyHealth Condition 1: null- Persons with epilepsy on antiepileptic drug therapy
CTRI/2017/10/009997All India Institute of Medical Sciences New Delhi
Recruiting
Not Applicable
Evaluation of the effect of the antiepiletic levetiracetum on seizure control and expression of MGMT in patients with gliomas (Phase II clinical trial)glioma
JPRN-UMIN000017531Department of Neurosurgery, Keio University School of Medicine20
Completed
Not Applicable
Reduction of concomitant antiepileptic medication after successful treatment with levetiracetam; a randomised open label study comparing delayed withdrawal to slow withdrawal.
ISRCTN72533351Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Completed
Not Applicable
Assessment of bone health and thyroid hormone function in children who are taking medications for epilepsyHealth Condition 1: G409- Epilepsy, unspecifiedHealth Condition 2: null- Those who are on anti-epileptic drug for more than 1 year
CTRI/2019/01/017107Bharati Vidyapeeth University Medical College Pune150